This task order is to (1) conduct toxicology studies of tenofovir nanoformulation with pharmacokinetics in mice (2) conduct inhalation toxicity studies of clofazimine rats and (3) support the…
Ended Awarded Last action
- Contract number
- 75N93020F00002
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,310,031
Award facts
- Contract value 100% obligated
- $1,310,031.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$4,470 | |
| Other Administrative Action | $0 | |
| Original award | $1,314,501 |
About this award
This is a task order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to SRI International, a non-profit research and development institute. The $1,310,031.26 cost-plus-fixed-fee task order is to conduct the following work: (1) toxicology studies of a tenofovir nanoformulation with pharmacokinetics in mice, (2) inhalation toxicity studies of clofazimine in rats, and (3) support the development of mitochondrial toxicity assays. This task order is not associated with a set-aside designation. SRI International has a robust history of providing advanced scientific and technical services to the U.S. federal government across multiple disciplines, including biomedical sciences. The organization has been awarded numerous federal contracts and grants by agencies such as the National Institutes of Health, DARPA, and the Department of Defense.
Description
This task order is to (1) conduct toxicology studies of tenofovir nanoformulation with pharmacokinetics in mice (2) conduct inhalation toxicity studies of clofazimine rats and (3) support the development of mitochondrial toxicity assays for mitocho
Quick answers
Who was awarded contract 75N93020F00002?
75N93020F00002 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2020.
How much is contract 75N93020F00002 worth?
The government has obligated $1,310,031 on 75N93020F00002.
Is contract 75N93020F00002 an order under another contract?
Yes. 75N93020F00002 is a delivery order under HHSN272201400006I, an indefinite delivery contract.
Was contract 75N93020F00002 competed?
The extent of competition for 75N93020F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award